These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23412797)

  • 21. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.
    Loi S; Haibe-Kains B; Desmedt C; Lallemand F; Tutt AM; Gillet C; Ellis P; Harris A; Bergh J; Foekens JA; Klijn JG; Larsimont D; Buyse M; Bontempi G; Delorenzi M; Piccart MJ; Sotiriou C
    J Clin Oncol; 2007 Apr; 25(10):1239-46. PubMed ID: 17401012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!
    Smeets SJ; Harjes U; van Wieringen WN; Sie D; Brakenhoff RH; Meijer GA; Ylstra B
    Clin Cancer Res; 2011 Aug; 17(15):4959-64. PubMed ID: 21673065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.
    Nagel JH; Peeters JK; Smid M; Sieuwerts AM; Wasielewski M; de Weerd V; Trapman-Jansen AM; van den Ouweland A; Brüggenwirth H; van I Jcken WF; Klijn JG; van der Spek PJ; Foekens JA; Martens JW; Schutte M; Meijers-Heijboer H
    Breast Cancer Res Treat; 2012 Apr; 132(2):439-48. PubMed ID: 21614566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.
    Natrajan R; Weigelt B; Mackay A; Geyer FC; Grigoriadis A; Tan DS; Jones C; Lord CJ; Vatcheva R; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Reis-Filho JS
    Breast Cancer Res Treat; 2010 Jun; 121(3):575-89. PubMed ID: 19688261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
    Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
    Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular classification of estrogen receptor-positive/luminal breast cancers.
    Geyer FC; Rodrigues DN; Weigelt B; Reis-Filho JS
    Adv Anat Pathol; 2012 Jan; 19(1):39-53. PubMed ID: 22156833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.
    Didraga MA; van Beers EH; Joosse SA; Brandwijk KI; Oldenburg RA; Wessels LF; Hogervorst FB; Ligtenberg MJ; Hoogerbrugge N; Verhoef S; Devilee P; Nederlof PM
    Breast Cancer Res Treat; 2011 Nov; 130(2):425-36. PubMed ID: 21286804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
    Tang P; Skinner KA; Hicks DG
    Diagn Mol Pathol; 2009 Sep; 18(3):125-32. PubMed ID: 19704256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
    Hu X; Stern HM; Ge L; O'Brien C; Haydu L; Honchell CD; Haverty PM; Peters BA; Wu TD; Amler LC; Chant J; Stokoe D; Lackner MR; Cavet G
    Mol Cancer Res; 2009 Apr; 7(4):511-22. PubMed ID: 19372580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translating Research into Practice: the Prosigna® (PAM50) Gene Signature Assay.
    Boccia RV
    Clin Adv Hematol Oncol; 2015 Jun; 13(6 Suppl 6):3-13. PubMed ID: 26191941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
    Tishchenko I; Milioli HH; Riveros C; Moscato P
    PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.
    Russnes HG; Lingjærde OC; Børresen-Dale AL; Caldas C
    Am J Pathol; 2017 Oct; 187(10):2152-2162. PubMed ID: 28733194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling in breast cancer.
    Morris SR; Carey LA
    Rev Endocr Metab Disord; 2007 Sep; 8(3):185-98. PubMed ID: 17464566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hopes and pitfalls of the molecular classification of breast cancer].
    Ryška A; Hovorková E; Sobande F; Rozkoš T; Laco J; Hornychová H
    Cesk Patol; 2015; 51(1):26-32. PubMed ID: 25671359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-driven integrated classification of breast cancer validated in over 7,500 samples.
    Ali HR; Rueda OM; Chin SF; Curtis C; Dunning MJ; Aparicio SA; Caldas C
    Genome Biol; 2014 Aug; 15(8):431. PubMed ID: 25164602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.
    Myhre S; Lingjærde OC; Hennessy BT; Aure MR; Carey MS; Alsner J; Tramm T; Overgaard J; Mills GB; Børresen-Dale AL; Sørlie T
    Mol Oncol; 2013 Jun; 7(3):704-18. PubMed ID: 23562353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.